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Abstract
Background: The rate of morbidity and mortality of hepatocellular carcinoma (HCC) in Taiwan has not lessened because of
difficulty in treating tumor metastasis. Norcantharidin (NCTD) is currently used as an anticancer drug for hepatoma, breast
cancer, and colorectal adenocarcinoma. NCTD possesses various biological anticancer activities, including apoptosis.
However, detailed effects and molecular mechanisms of NCTD on metastasis are unclear. Thus, HCC cells were subjected to
treatment with NCTD and then analyzed to determine the effects of NCTD on cell metastasis.
Methodology/Principal Findings: Modified Boyden chamber assays revealed that NCTD treatment inhibited cell migration
and invasion capacities of HCC cells substantially. Results of zymography and western blotting showed that activities and
protein levels of matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (u-PA) were inhibited by NCTD.
Western blot analysis showed that NCTD inhibits phosphorylation of ERK1/2. Testing of mRNA level, quantitative real-time
PCR, and promoter assays evaluated the inhibitory effects of NCTD on MMP-9 and u-PA expression in HCC cells. The
chromatin immunoprecipitation (ChIP) assay for analyzing the genomic DNA sequences bound to these proteins was
reactive to the transcription protein nuclear factor (NF)-kappaB, which was inhibited by NCTD. The expression of NF-kappa B
was measured by western blot analysis, which revealed decreased nuclear-factor DNA-binding activity after NCTD
treatment.
Conclusions: NCTD inhibited MMP-9 and u-PA expression through the phosphorylation of ERK1/2 and NF-kappaB signaling
pathway which serves as a powerful chemopreventive agent in HCC cell metastasis.
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Introduction
Hepatocellular carcinoma (HCC) is a common malignant
neoplasm and cause of cancer-related death in Asian countries.
The mortality rate of HCC in Taiwan has not decreased, mainly
because of the difficulty of treatment related to invasion and
metastasis [1]. Generally, metastasis of cancer cells involves
multiple processes and various cytophysiological changes, includ-
ing altered adhesive capability between cells and the extracellular
matrix (ECM) and damaged intercellular interaction. Degradation
of ECM by cancer cells through proteases such as serine
proteinase, matrix metalloproteinases (MMPs), cathepsins, and
plasminogen activator (PA) may lead to the separation of the
intercellular matrix to promote cancer cell mobility, and may
eventually lead to metastasis. Among the involved proteases,
MMP-2, MMP-9, and u-PA are most vital for the degradation of
base membranes, and are therefore deeply involved in cancer
invasion and metastasis [2–3]. Various factors such as growth
factors, cytokines, certain chemicals, or even physical stimulation
may promote MMP expression, whereas TGF-b, retinoic acids,
and glucocorticoids may inhibit MMPs. In addition, u-PA or
tissue-type plasminogen activator (t-PA) may activate a series of
protein degradation reactions to regulate or activate MMPs. MMP
activity is prone to the inhibition of endogenous tissue by
metalloproteinases (TIMPs), which are specific inhibitors of
MMPs, and the imbalance between MMPs and TIMPs may
contribute to ECM degradation or deposition [3,4].
Cantharidin and norcantharidin (NCTD, exo-7-oxabicylo-
[2.2.1] heptane-2,3-dicarboxylic anhydride) are known to possess
anticancer activities because they suppress the activity of serine/
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31055threonine protein phosphates [5,6]. In our previous study, the
structure-activity relationship (SAR) of cantharidin analogues
suggested that anhydride ether oxygen in these analogues may
correlate with HCC survival suppression, and the elimination of
bridging ether oxygen on the ring can decrease cytotoxicity.
However, cantharidin is unsuitable for cancer therapy because of
its high cytotoxicity in vitro [IC (50)=21 mM in primary cultured
rat hepatocytes] [7]. The demethylated analogue of cantharidin is
NCTD, which reduces the toxicity of cantharidin and is a
potential anticancer drug for various cancer cells. A recent study
showed that an NCTD-Nd3II derivative possesses anti-hepatoma
activity, both in vitro and in vivo. It exerts its antiproliferative activity
through apoptosis, G2/M cell-cycle arrest, and regulation of cyclin
B1/cdc-2, p21, and Bcl-2/Bax [8]. Yang et al. reported that
NCTD induces apoptosis of breast cancer cells through activities
of mitogen-activated protein kinases and signal transducers and
activators of transcription. Consequently, NCTD may disturb cell-
cycle distribution of breast cancer cells through p53- and Chk-
related pathways [9]. Moreover, Liao et al. reported that NCTD
induces cell cycle arrest and inhibits progression of human
leukemic Jurkat T cells through mitogen-activated protein
kinase-mediated regulation of interleukin-2 production [10].
Furthermore, Chang et al. showed that NCTD induced
cytotoxicity in HepG2 cells by apoptosis, which is mediated
through ROS generation and mitochondrial pathways [11], and a
number of authors suggested that NCTD demonstrates anti-
proliferative effects on human HepG2 cells in cell cultures [12].
NCTD thus inhibits the cell growth of various cancers by inducing
apoptosis in cancer cells [13–21]. Research has confirmed that
NCTD not only induces apoptosis, but also shows an anti-
metastasis effect in certain cancer cells. Luan et al. reported that
NCTD could reduce human lung cancer cell growth and
migration because of inhibitory effects in human lung cancer
A549 cells [13]. Chen et al. showed that NCTD demonstrates an
inhibitory effect on tumor invasion and metastasis in colorectal
adenocarcinoma cells. NCTD possesses anti-angiogenic activity
and could be useful in anticancer therapy as an anti-metastatic and
anti-angiogenic agent in colorectal adenocarcinoma CT26 cells
[15,22,23]. Studies on the inhibitory effects of NCTD on HCC
cell invasion and migration behavior, however, are no literature
report, and these effects warrant further examination. Thus, we
studied the effects, mechanisms, and pathway of NCTD in HCC
metastasis.
Results
Effect of NCTD on the Viability of Huh7 Cells and Normal
Hepatocytes
The cytotoxic effects of NCTD at various concentrations (0–
20 mM) on Huh7 cells are shown in Fig. 1A. The MTT assay
showed that, at the highest concentration of 20 mM, NCTD
altered HCC cell viability, as previously described [7]. Thus, we
used a concentration range of NCTD lower than this for all
subsequent experiments. Furthermore, NCTD also did not alter
the cell viability of normal hepatocytes (Figure S1).
We further investigated the effect of NCTD on the cell cycle
regulation. Our results showed that treatment of Huh7 cells with
NCTD (0–20 mM) for 24 h did not increase the incidence of
apoptosis as evidenced by without significant changes in the sub
G1 population between control and NCTD-treated Huh7 cells.
Moreover, the proliferation rate of Huh7 cells was also not
affected by NCTD due to the number of cells in S-phase was not
changed significantly after treatment of NCTD for 24 h (Figure
S2).
Effects of NCTD on In vitro Wound Closure, Invasion, and
Migration in Huh7 Cells
Figure 1B displays findings from a wound closure assay to
determine the effects of NCTD on the migration of Huh7 cells. It
shows representative photographs of Huh7 cells migrating into
scratch wounds under treatment with NCTD. Figures 1C and 1D
show the effect of NCTD on cell migration and invasion in Huh7
cells that were treated with 0, 2.5, 5, and 10 mM of NCTD for
16 h (cell migration) and 24 h (cell invasion). Using a cell
migration and invasion assay with a Boyden chamber, we showed
that NCTD reduced the invasion and migration of Huh7 cells
substantially in a concentration-dependent manner. Similar anti-
migration effect of NCTD was observed in SK-Hep1 HCC cell
line (Figure S3).
Effect of NCTD on the Protein Levels of MMPs and their
Endogenous Inhibitors
Huh7 cells were treated with NCTD (0, 2.5, 5, and 10 mM) for
24 h, and then subjected to gelatin zymography and casein
zymography for analysis of MMP-9 and u-PA activity, respective-
ly. As shown in Fig. 2A and 2C, NCTD treatment may lead to
reduced activity of MMP-9 and u-PA in a dose-dependent
manner. Similar effect on MMP-9 activity of NCTD was also
observed in SK-Hep1 HCC cell line (Figure S4). Figure 2B shows
a western blotting analysis of the protein levels of MMP-9, u-PA,
PAI-1, and TIMP-1. MMP-9, u-PA, PAI-1, and TIMP-1 protein
levels were adjusted with b-actin. Protein levels of MMP-9 and u-
PA decreased significantly, whereas those of their respective
inhibitors PAI-1 and TIMP-1 increased (Figure 2D). In addition to
MMP-9, we found that NCTD also can inhibit the activation of
focal adhesion kinase, FAK, significantly (Figure S5). This result
suggested that the inhibition of FAK activation by NCTD might
also contribute to the migration/invasion inhibition in the Huh7
cells.
Effect of NCTD on the Transcriptional Level of MMP-9 and
u-PA
Testing of mRNA, reverse transcription-PCR, quantitative real-
time PCR, and promoter reporter assays evaluated the inhibitory
effects of NCTD on MMP-9 and u-PA expression in Huh7 cells.
Huh7 cells were treated with 0, 2.5, 5, and 10 mM of NCTD for
24 h and were then subjected to RT-PCR and real time-PCR to
analyze mRNA levels. MMP-9 and u-PA mRNA levels decreased
considerably in a concentration-dependent manner after treat-
ment with various concentrations of NCTD (Figs. 3A and 3B).
Figures 3C and 3D show that the luciferase activities of MMP-9
and u-PA were significantly suppressed, respectively, which was
determined using a luciferase assay kit. These results show that
NCTD regulates the expression of MMP-9 and u-PA, at least
partially, at a transcriptional level.
NF-kB is the Key Regulator for the Transcriptional
Inhibition of MMP-9 and u-PA by NCTD
Sequence analysis of the MMP-9 and u-PA promoter revealed
a number of potential cis-acting regulatory elements, including
AP-1, NF-kB, and SP-1, which could be involved in the
regulation of MMP-9 and u-PA expression. We performed a
chromatin immunoprecipitation (ChIP) assay to investigate the
involvement of transcription factors in the transcriptional
inhibitory effects of NTCD on MMP-9 (Figs. 4A to 4B). A
quantitative real-time PCR assay showed that NCTD suppressed
binding of NF-kB to the MMP-9 and u-PA promoters
substantially (Figs. 4A to 4B).
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PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31055Figure 1. Effect of NCTD on cell viability, in vitro wound closure, cell migration and invasion in Huh7 cells. (A) Huh7 cells were treated
with NCTD (0, 2.5, 5, 10 and 20 mM) for 24 h before being subjected to a MTT assay for cell viability. The values represented the means 6 SD of at
least three independent experiments. (B) Huh7 cells were wounded and then treated with vehicle (DMSO) or NCTD (2.5, 5 and 10 mM) for 0 h, 12 h
and 24 h in 0.5% FBS-containing medium. At 0, 12 and 24 h, phase-contrast pictures of the wounds at three different locations were taken. (C & D)
Figure C&D showing the cell migration and invasion were measured using a Boyden chamber for 16 h and 24 h with polycarbonate filters
respectively. The migration and invasion abilities of Huh7 cells were quantified by counting the number of cells that invaded to the underside of the
porous polycarbonate as described in the Materials and Methods section. The values represented the means 6 SD of at least three independent
experiments. *P,0.05 as compared with the vehicle group.
doi:10.1371/journal.pone.0031055.g001
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regulation of NCTD on MMP-9 and u-PA in Huh7 cells, we
evaluated the effect of NCTD on nuclear translocation of NF-kB.
Treatment of Huh7 cells with 2.5 and 10 mM NTCD reduced
nuclear translocation of NF-kB and phosphorylation of IkBa
(Figs. 4C and 4D). The findings indicate that NCTD might induce
transcriptional inhibition of MMP-9 and u-PA in Huh7 cells by
suppressing NF-kB nuclear translocation and MMP-9 and u-PA-
promoter binding activity.
Effect of MAPK and PI3K/Akt pathways by NCTD
Because the inhibitory effect of NCTD on the cell migration/
invasion and proteinases was revealed, the effects of NCTD on the
expressions of MAPK and PI3K/Akt pathways have been
investigated by western blotting to clarify their underlying
mechanisms. Western blotting showed that NCTD could reduce
the phosphorylation of ERK1/2 (Fig. 5A) in Huh7 cells.
According to densitometric analyses of blots versus the control,
treatment of NCTD at 10 mM could result in a reduction in
phosphorylation of ERK1/2 to 45%. However, phosphorylation
of p38, JNK 1/2, and PI3K/Akt pathways remained unaffected
(Figs. 5B–5D).
Effect of NCTD on u-PA and MMP-9 Expression, in vitro
wound closure, and Migration and Invasion of HCC cells
with U0126
To further delineate whether the inhibition of proteinase,
invasion, and migration by NCTD occurred mainly through
inhibition of the Erk1/2 signaling pathway, we investigated the
effects of a specific inhibitor of the Erk1/2 pathway (U0126) on
Huh7 cells. The results show that combined treatment of the
inhibitor with NCTD further decreased MMP-9 and u-PA
expression (Figs. 6A and 6B). Additionally, we observed a similar
trend for the inhibition of Huh7 migration and invasion, with sole
treatment and with combined treatment (Figs. 6C to 6E).
Therefore, the inhibition of the Erk1/2 signaling pathways may
result in reduced expression of MMP-9 and u-PA, as well as
reduced tumor cell invasion.
Discussion
NCTD has several therapeutic effects on cancer cells, including
inhibition of cell proliferation, anti-angiogenic effects, cell-cycle
blockage, and induction of cell apoptosis. Therefore, NCTD has
been used for the treatment of primary hepatoma, esophageal
Figure 2. Effects of NCTD on the activity and protein level of MMP-9, u-PA and the protein level of the endogenous inhibitor TIMP-1
and PAI-1. (A) Huh7 cells were treated with NCTD (0, 2.5, 5 and 10 mM) for 24 h and then subjected to gelatin and casein zymography to analyze the
activity of MMP-9 and u-PA respectively. (B) Huh7 cells were treated with NCTD (0, 2.5, 5 and 10 mM) for 24 h and then subjected to western blotting
to analyze the protein levels of MMP-9, u-PA, PAI-1 and TIMP-1. (C&D) Quantitative results of MMP-9, u-PA, PAI-1 and TIMP-1 protein levels which
were adjusted with b-actin protein level. The values represented the means 6 SD of at least three independent experiments. *P,0.05 as compared
with the vehicle group.
doi:10.1371/journal.pone.0031055.g002
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[24,25]. In hepatoma, a high concentration level of NCTD (50–
100 mM) is required for a therapeutic effect on the apoptosis
pathway in HCC cells, but the toxicity of NCTD remains
relatively high toward normal hepatocytes. Recent studies
reported that a low concentration of NCTD has anti-invasion
and anti-migration effects in lung cancer A549 cells and colorectal
adenocarcinoma cells [13,18,23], but its anti-metastatic effects in
hepatoma remain unclear. Thus, we designed this study to verify
whether a low concentration level of NCTD has anti-invasion and
anti-migration effects in hepatoma. Our results show that a low
concentration of NCTD (,10 mM) has anti-invasion and anti-
migration effects in HCC cells. To our knowledge, this is the first
demonstration of the anti-metastatic effect of NCTD on HCC.
In general, metastasis of cancer cells involves multiple processes
and various cytophysiological changes. The degradation or
breakdown of the ECM through protease is a critical step in
tumor invasion or migration. This phenomenon leads to the
separation of the intercellular matrix to promote cancer cell
mobility, eventually leading to metastasis. Among the involved
proteases, MMP-2, MMP-9, u-PA, and cathepsins reportedly play
the most important roles in cancer invasion and metastasis [1–3].
In this study, we verified that NCTD has an inhibitory effect on
metastasis through MMP-9 and u-PA in HCC cells, which is a
similar conclusion of our previous research. Chen et al.
demonstrated that NCTD has an inhibitory effect on metastasis
because it downregulates MMP-9 expression by inhibiting Sp1
transcriptional activity in colorectal cancer CT26 cells [22].
However, no studies on anti-invasion and anti-metastasis in
hepatoma exist, and the bioactive ingredients and mechanisms of
NCTD remain unclear. Additionally, medicinal plants such as
Chrysanthemum indicum and Ganoderma lucidum have been reported to
cause downregulation of MMP-2 and MMP-9 expression in HCC
metastasis with similar results to NCTD in HCC metastasis. Wang
et al. showed that Chrysanthemum indicum ethanolic extract (CIE)
suppressed the proliferation and invasion of HCC cells lines
(MHCC97H cells) substantially, with notable decreases in MMP-2
and MMP-9 expression and simultaneous increases in TIMP-1
and TIMP-2 expression [26]. Weng et al. revealed that Ganoderma
lucidum extract (GLE) contains lucidenic acid that has an anti-
invasion, antiproliferative, and anti-metastatic effect on human
hepatoma HepG2 cells though inhibitory effects on MMP-9
expression [27]. However, the present study’s zymography data
indicated that the secreted protein level of MMP-2 from Huh7
Figure 3. NCTD suppresses MMP-9 and u-PA expression at a transcriptional level. Huh7 cells were treated with NCTD (0, 2.5, 5 and 10 mM)
for 24 h and then subjected to (A) Reverse Transcription-PCR and (B) quantitative real-time PCR to analyze the mRNA expression of MMP-9, or u-PA.
(C&D) MMP-9 and u-PA promoter reporter assay to analyze the promoter activity of MMP-9 and u-PA respectively. Luciferase activity, determined in
triplicates, was normalized to b-galactosidase activity. The values represented the means 6 SD of at least three independent experiments. *P,0.05 as
compared with the vehicle group.
doi:10.1371/journal.pone.0031055.g003
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Therefore, we conclude that MMP-9 and u-PA are the most
important proteases in metastasis of human hepatoma. However, a
number of authors also reported that NCTD could decrease
invasion through the expression of a- and b-catenin in colorectal
adenocarcinoma cells and could regulate their adhesion molecules
in the anti-metastatic process [23]. Thus, NCTD may use other
pathways or proteases to achieve anti-metastasis in HCC, and we
require more studies to substantiate any other anti-metastasis
mechanisms and protease expression of NCTD.
Mitogen-activated protein kinases (MAPKs) are a family of
serine/threonine kinases, including Jun-N-terminal kinase (JNK),
P38, and extracellular signal-regulated kinase (ERK), which
respond to chemical and physical stress by connecting cell-surface
receptor responses to the activity of regulatory proteins. MAPKs
activation is followed by phosphorylation of a variety of cytosolic
substrates and is involved in numerous cellular programs such as
cell proliferation, cell differentiation, cell invasion, cell migration,
and cell death [28,29]. Moreover, MAPK pathways in the
regulation of MMPs and u-PA expression in tumor-cell invasion
have been studied extensively [28–31]. We found that NCTD
inhibits phosphorylation of ERK1/2, leading to downregulation of
MMP-9 expression in HCC cells. However, other studies found
that NCTD could block proliferation and induce anoikis-mediated
apoptosis through the modulation of JNK/mitogen-activated
protein kinase (MAPK) activation [15]. Furthermore, Luan et al.
determined that NCTD treatment in A549 cell migration may
inhibit the phosphorylation of Akt in lung-cancer cells [13]. Thus,
the antitumor effects of NCTD may involve different pathways
according to different cancer-cell types. The PI3K-Akt signaling
pathway plays another crucial role in MMPs for u-PA gene
regulation, cell survival, and tumor-cell invasion [2,32]. However,
Saxena NK et al. reported that concomitant activation of JAK/
STAT, PI3K/AKT, and ERK signaling is involved in leptin-
mediated promotion of invasion and migration of hepatocellular
carcinoma cells [33]. Therefore, we require further research to
confirm different pathways under varying environments.
MMPs and u-PA gene expression are primarily regulated at the
transcriptional and posttranscriptional levels and at the protein
level through their activators and inhibitors and cell surface
localization [2,34]. Transcription of MMPs and the u-PA gene is
regulated by upstream sequences, including motifs corresponding
to NF-kB, AP-1, or SP-1 binding sites [2,34,35]. The activation of
NF-kB and AP-1 downstream of MAPK or PI3K-Akt pathways is
involved in numerous pathological processes, such as inflamma-
tion, cancer-cell adhesion, invasion, metastasis, and angiogenesis
[36,37]. In this study, we found that NCTD inhibited the binding
activity of NF-kB to MMP-9 and u-PA promoters in Huh7 cells,
while AP-1 and SP-1 did not reduce the phenomenon. NF-kBi sa
transcription nuclear factor that could promote tumorigenesis, and
is linked to cell invasion and metastasis. Suppression of NF-kB
activation is effective in the prevention and treatment of cancer
[37]. Nagendraprabhu et al. showed that astaxanthin inhibits
tumor invasion by decreasing extracellular matrix production and
induces apoptosis in experimental rat-colon carcinogenesis by
modulating the expressions of ERK-2, NF-kB, and COX-2 [38].
Ma et al. reported that genistein potentiates have an effect similar
to arsenic trioxide against human hepatocellular carcinoma by
role of Akt and NF-kB [39]. Cimmino et al. showed that NCTD
impairs medulloblastoma growth by inhibition of Wnt/b-catenin
signaling [40]. Additionally, the phosphorylation of IkBa releases
NF-kB subunits, activating NF-kB, and the subunits are then
translocated from cytosol into the nucleus to regulate gene
expression at a transcriptional level. Our study is the first to
validate its pathway. We found that NCTD treatment results in an
inhibition of NF-kB DNA-binding activity, which is accompanied
by inhibition of the phosphorylation of IkBa.
In conclusion, this study showed that NCTD exerts an
inhibitory effect on several essential steps of metastasis, including
cell invasion and migration, by regulating the activities of
metastasis-associated proteases and their natural inhibitors. The
results show that NCTD may be a powerful candidate for
developing preventive agents against cancer metastasis. Moreover,
we demonstrated that NTCD can inhibit ERK1/2 phosphoryla-
tion effectively, by reducing NF-kB DNA-binding activities,
leading to MMP-9 downregulation and u-PA expression. Clarify-
ing signal transduction mediators and transcriptional factors
involved in the NTCD anti-metastatic process on the human
hepatoma cell line might effectuate the development of specific
mediators to inhibit undesired cell metastasis. NTCD should be
tested further in vivo to justify its effectiveness in the prevention of
hepatoma invasion or migration.
Materials and Methods
Cell culture and NCTD treatment
HCC (Huh7) cells obtained from Food Industry Research and
Development Institute (Hsinchu, Taiwan) was cultured in
Dulbecco’s modified Eagle’s medium (Life Technologies, Grand
Island, NY, USA), 10% fetal bovine serum, 2 mM glutamine,
100 U/mL penicillin, 100 mg/mL streptomycin, and 400 ng/mL
hydrocortisone. All cell cultures were maintained at 37uCna
humidified atmosphere of 5% CO2. For NCTD treatment,
appropriate amounts of stock solution of NCTD (Sigma chemical
Co., St. Louis, MO, USA) were added into culture medium to
achieve the indicated concentrations and then incubated with cells
for indicated time periods, whereas dimethyl sulfoxide solution
without NCTD was used as blank reagent.
Determination of cell viability (MTT assay)
For cell viability experiment, a microculture tetrazolium (3-(4,5-
dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide) colori-
metric assay was performed to determine the cytotoxicity of
NCTD [41,42]. Huh-7 cells were seeded in 24-well plates at a
density of 5610
4 cells/well and treated with NCTD at a
concentration between 0 and 20 mMa t3 7 uC for 24 h. After the
exposure period, the media was removed, and cells were washed
with phosphate buffered saline (PBS) and then incubated with
20 mL MTT (5 mg/mL) (Sigma chemical Co., St. Louis, MO,
USA) for 4 h. The viable cell number per dish is directly
Figure 4. Critical role of NF-kB in NCTD-induced transcriptional inhibition of MMP-9 and u-PA in Huh7 cells. Huh7 cells were treated
with NCTD 10 mM for 24 h and then the nuclear fraction was prepared as described in ‘‘Materials and Methods’’. (A and B) ChIP analysis of the
association of various transcription factors with the MMP-9 and u-PA promoter region in Huh7 cells. (C and D) Representative results of NF-KB protein
levels and phosphorylation of IkBa by Western blot analysis. Quantitative results of NF-kB protein levels, which were adjusted with the internal
control Fibrillian or GAPDH protein level. The values represented the means 6 SD of at least three independent experiments. *P,0.05 as compared
with the vehicle group.
doi:10.1371/journal.pone.0031055.g004
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31055Figure 5. Effects of NCTD on the MAPKs pathway and PI3K/Akt signalings. Huh7 cells were cultured in various concentrations of NCTD (0,
2.5, 5, 10 mM) for 24 hours, and then the cell lysates were subjected to SDS–PAGE followed by western blots with (A) anti-ERK1/2, (B) anti-JNK, (C)
anti-p38 and (D) anti-PI3K and anti-Akt (total and phosphorylated) antibodies as described in Materials and Methods. Determined activities of these
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measured spectrophotometrically at 563 nm following solubiliza-
tion with isopropanol.
In vitro wound closure
Huh7 cells (1610
5 cells/well) were plated in 6-well plates for
24 h, wounded by scratching with a pipette tip, then incubated
with DMEM medium containing 0.5% FBS and treated with or
without NCTD (0, 2.5, 5, 10 mM) for 0, 12, and 24 h. Cells were
photographed using a phase-contrast microscope (6100).
Cell invasion and migration assays
Cell invasion and migration were assayed according to the
methods described by Yang et al. [43]. After a treatment with
NCTD (0, 2.5, 5 and 10 mM) for 24 h, surviving cells were
harvested and seeded to Boyden chamber (Neuro Probe, Cabin
John, MD, USA) at 10
4 cells/well in serum free medium and then
incubated for 24 hours at 37uC. For invasion assay, 10 mL
Matrigel (25 mg/50 mL; BD Biosciences, MA, USA) was applied
to 8 mm pore size polycarbonate membrane filters and the bottom
chamber contained standard medium. Filters were then air-dried
for 5 h in a laminar flow hood. The invaded cells were fixed with
100% methanol and stained with 5% Giemsa. Cell numbers were
counted under a light microscope. The migration assay was
carried out as described in the invasion assay with no coating of
Matrigel [44].
Determination of MMP-9 and u-PA by zymography
The activities of MMP-9 in conditional medium were measured
by gelatin zymography protease assays as previously described
[43]. Briefly, collected media of an appropriate volume (adjusted
by vital cell number) were prepared with SDS sample buffer
without boiling or reduction and subjected to 0.1% gelatin-8%
SDS-PAGE electrophoresis. After electrophoresis, gels were
washed with 2.5% Triton X-100 and then incubated in reaction
buffer (40 mM Tris–HCl, pH 8.0; 10 mM CaCl2 and 0.01%
NaN3) for 12 h at 37uC. Then gel was stained with Coomassie
brilliant blue R-250. Visualization of u-PA activity was performed
as previously described [45]. Briefly, 2% casein (w/v) and 20 mg/
mL plasminogen were added to 8% SDS-PAGE gel, and then
performed as described in the gelatin zymography.
RNA preparation and TaqMan quantitative real-time PCR
Total RNA was isolated from HCC cells using Trizol (Life
Technologies, Grand Island, NY) according to the manufacturer’s
instructions. Quantitative real-time PCR analysis was carried out
using Taqman one-step PCR Master Mix (Applied Biosystems).
100 ng of total cDNA was added per 25 ml reactions with MMP-9,
u-PA or GAPDH primers and TaqMan probes. The oligonucle-
otide sequences of TaqMan probes and primers were described in
Table S1. Quantitative real-time PCR assays were carried out in
triplicate on a StepOnePlus sequence detection system. The
threshold was set above the non-template control background and
within the linear phase of target gene amplification to calculate the
cycle number at which the transcript was detected.
Preparation of total cell lysates and nuclear fraction
For total cell lysates preparation, cells were rinsed with PBS
twice and scraped with 0.2 mL of cold RIPA buffer containing
protease inhibitors cocktail, and then vortexed at 4uC for 10 min.
Cell lysates were subjected to a centrifugation of 10,000 rpm for
10 min at 4uC, and the insoluble pellet was discarded. Nuclear
extracts were obtained using a modification of a previously
described method [46]. Briefly, harvested cells were scraped and
lysed with buffer A (10 mM HEPES, 10 mM KC1, 0.1 mM
EDTA, 1.5 mM MgCl2, 0.2% NP40, 1 m MDTT, and 0.5 m
Mphenylmethylsulfonyl fluoride), followed by vortexing to shear
the cytoplasmic membranes and nuclear pellets were collected by
a centrifugation at 3000 rpm for 30 s at 4uC. Nuclear proteins
were extracted with high-salt buffer B (20 mM HEPES, 25%
glycerol, 1.5 mM MgCl2, 0.1 mM EDTA, 420 mM NaCl, 1 mM
DTT, and 0.5 mM phenylmethylsulfonyl fluoride). The protein
concentration of total cell lysates and nuclear fraction were
determined by Bradford assay [47].
Western blot analysis
The cell lysates or nuclear extracts were separated in a 10%
polyacrylamide gel and transferred onto a nitrocellulose mem-
brane. The blot was subsequently incubated with 5% non-fat milk
in Tris-buffered saline (20 mM Tris, 137 mM NaCl, pH 7.6) for
1 h to block non-specific binding and then overnight with
polyclonal antibodies against MMP-9, TIMP-1, u-PA, PAI-1,
PI3K, NF-kB, Fibrillian (internal control for nuclear) or with the
specific antibodies for unphosphorylated or phosphorylated
activated forms of the corresponding ERK 1/2, JNK 1/2, p38,
Akt and IkBa. Blots were then incubated with a horseradish
peroxidase goat anti-rabbit or anti-mouse IgG for 1 h. Afterwards,
signal was detected by using enhanced chemiluminescence (ECL)
commercial kit (Amersham Biosciences) and relative photographic
density was quantitated by scanning the photographic negatives on
a gel documentation and analysis system (AlphaImager 2000,
Alpha Innotech Corporation, San Leandro, CA, USA).
Transfection and MMP-9 or u-PA promoter-driven
luciferase assays
Huh7 cells were seeded at a concentration of 5610
4 cells per
well in 6-well cell culture plates. After 24 h of incubation, pGL3-
basic (vector) and MMP-9 or u-PA promoter plasmid were co-
transfected with a b-galactosidase expression vector (pCH110) into
cells using Turbofect (Fermentas, Carlsbad, CA). After 12 h of
transfection, cells were treated with vehicle or NCTD (0, 2.5, 5
and 10 mM) for 24 h. The cell lysates were harvested, and
luciferase activity was determined using a luciferase assay kit. The
value of the luciferase activity was normalized to transfection
efficiency and monitored by b-galactosidase expression.
Chromatin immunoprecipitation analysis (ChIP)
Chromatin immunoprecipitation analysis was performed as
described previously [46]. DNA immunoprecipitated with anti-
NF-kB, anti-AP-1 and anti-SP-1 was purified and extracted using
phenol-chloroform. Immunoprecipitated DNA was analyzed by
PCR or quantitative PCR by using specific primers as described in
Table S1.
Statistical analysis
Statistical significances of differences throughout this study were
analyzed by One-way ANOVA test to compare differences
between treatments and followed up using Dunnett’s multiple
proteins were subsequently quantified by densitometric analyses with that of control being 100% as shown just below the gel data. The values
represented the means 6 SD of at least 3 independent experiments. *P,0.05 as compared with the vehicle group.
doi:10.1371/journal.pone.0031055.g005
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PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31055Figure 6. Effect of NCTD and Erk inhibitor (U0126) on MMP-9, u-PA expression, in vitro wound closure, cell migration and invasion
in Huh7 cells. (A–B) Huh7 cells were pre-treated with U0126 for 30 min and then incubated in the presence or absence of NCTD for 24 h, and then
the cell lysates were subjected to SDS–PAGE followed by western blots with anti-MMP-9, anti-u-PA, anti-Erk1/2 (total and phosphorylated) antibodies
as described in Materials and Methods. (C–E) Huh7 cells were pre-treated with U0126 for 30 min and then incubated in the presence or absence of
NCTD for 24, Huh7 cells were then subjected to in vitro wound closure, cell migration and invasion assay. The migration and invasion abilities of Huh7
cells were quantified by counting the number of cells that invaded to the underside of the porous polycarbonate as described in the Materials and
Methods section. The values represented the means 6 SD of at least three independent experiments. *P,0.05 as compared with the vehicle group.
doi:10.1371/journal.pone.0031055.g006
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to be statistically significant and the experiments were repeated
three times.
Supporting Information
Figure S1 Effect of NCTD on cell viability in normal
hepatocytes. Normal hepatocytes were treated with NCTD (0,
2.5, 5 and 10 mM) for 24 h before being subjected to a MTT assay
for cell viability. The values represented the means 6 SD of at
least three independent experiments.
(JPG)
Figure S2 Effects of NCTD on the cell cycle regulation in
Huh7 cells. Huh7 cells were treated with NCTD (0,10 mM) for
24 h and then subjected to flow cytometry to analyze the cell cycle
regulation.
(JPG)
Figure S3 Effects of NCTD on the cell migration in SK-
Hep1 cells. SK-Hep1 cells were treated with NCTD (0,10 mM)
for 24 h and then subjected to a Boyden chamber for 16 h with
polycarbonate filters respectively. The migration abilities of SK-
Hep1 cells were quantified by counting the number of cells that
invaded to the underside of the porous polycarbonate as described
in the Materials and Methods section. The values represented the
means 6 SD of at least three independent experiments. *P,0.05
as compared with the vehicle group.
(JPG)
Figure S4 Effects of NCTD on the MMP-9 activity in SK-
Hep1 cells. SK-Hep1 cells were treated with NCTD (0,10 mM)
for 24 h and then subjected to gelatin zymography to analyze the
activity of MMP-9. The values represented the means 6 SD of at
least three independent experiments. *P,0.05 as compared with
the vehicle group.
(JPG)
Figure S5 Effects of NCTD on the FAK expression in
Huh7 cells. Huh7 cells were treated with NCTD (0,10 mM) for
24 h and then subjected to Western blotting to analyze the
expression of FAK.
(JPG)
Table S1 Primers list for real-time PCR and ChIP
assay.
(DOC)
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